Pfizer Inc. may make counter bid for Ranbaxy: report
HONG KONG (MarketWatch) -- Shares of Ranbaxy Laboratories Ltd. climbed as much as 3.4% in Mumbai trading Friday after the local daily Business Standard reported U.S.-based Pfizer Inc. may make a counteroffer for the 65% stake in the generic drug... 5 months ago
MarketWatch Personal Finance Click here to Read the Full Story